Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

946986

	registered interest
	date	23/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department issues to help people better understand their diabetes.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	167325
	answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>'Healthier You: The NHS Diabetes Prevention Programme' started in 2016 and currently covers three quarters of the population of England. At the end of May 2018, nearly 215,000 people had been referred into the service, with over 95,000 taking up the offer of a programme.</p><p>By 2020, the programme will support 100,000 people at risk of diabetes each year across England. Those referred will get tailored, personalised help to reduce their risk including education on healthy eating and lifestyle and bespoke physical exercise programmes.</p><p>NHS England has invested £10.5 million transformation funding in 2018/19 (and a similar amount in 2017/18) to provide approximately 96,000 additional structured education places in 137 clinical commissioning groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:50:07 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

797514

	registered interest
	date	29/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Thyroid Gland: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what medicines NHS England has approved for patients with thyroid conditions
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	116477
	answer	answer is ministerial correction date of answer 07/12/2017 answer text <p><del class="ministerial">For unbranded generics the Government relies on completion to keep prices down which generally works well and has led to low prices of these medicines. We alert the Competition and Markets Authority (CMA) when we believe that competition does not work. In the case of liothyronine, the CMA is currently investigating Concordia’s potential abuse of its dominant position to overcharge the National Health Service for liothyronine.</del></p><p> </p><p><del class="ministerial">In primary care community pharmacies are incentivised to source products at the lowest possible cost by allowing them to retain the medicines margin (the difference between what the NHS reimburses a pharmacy for a product and how much the pharmacy purchases it for) up to £800 million in England. In secondary care, competitive tenders ensure value-for-money to the NHS.</del></p><p><ins class="ministerial"> <p><ins class="ministerial">NHS England is not responsible for approving medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines and medical devices work and are acceptably safe. The National Institute for Health and Care Excellence makes recommendations for the National Health Service on whether medicines and other treatments represent a clinically and cost effective use of NHS resources.</ins></p><p><ins class="ministerial"><strong> </strong></ins></p><p><ins class="ministerial">A list of medicines licensed by the MHRA for the treatment of thyroid conditions is attached. The list is split into two sections because thyroid conditions can be split into either those associated with an overactive thyroid (hyperthyroidism), or an underactive thyroid (hypothyroidism). The list contains only those medicines licensed for overactive and underactive thyroid. It should be noted that not all of the medicines listed will be available on the market at any one time. </ins></p></ins></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 15:27:25 question first ministerially corrected 07/12/2017 18:20:31 answering member 4067 label Biography information for Steve Brine attachment 1 file name 2017 12 06 Thyroid medicines formatted.xls title List of thyroid medicines previous answer version 27995 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

771530

	registered interest
	date	16/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how his Department defines a long-term health condition.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	108040
	answer	answer is ministerial correction date of answer 24/10/2017 answer text <p>A long-term health condition (LTC) can be defined as a condition that cannot be cured but can be managed through the use of medication and/or therapy.</p><p> </p><p>This is how LTC are defined by NHS Choices; further information can be found here:</p><p><a href="http://www.nhs.uk/Livewell/workplacehealth/Documents/ChronicConds_LineManagers_Factsheet_A4.pdf" target="_blank">www.nhs.uk/Livewell/workplacehealth/Documents/ChronicConds_LineManagers_Factsheet_A4.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/10/2017 10:55:20 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

1015550

	registered interest
	date	27/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pulmonary Arterial Hypertension
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what treatments are available on the NHS for pulmonary hypertension; and what assessment he has made of the adequacy of the accessibility of those treatments.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	196303
	answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>A number of treatments are available for pulmonary hypertension (PH). If PH is caused by another condition, such as a heart or lung problem, treatments will focus on the underlying condition. The full range of treatments for PH is detailed on the NHS website at the following link:</p><p> </p><p><a href="https://www.nhs.uk/conditions/pulmonary-hypertension/treatment/" target="_blank">https://www.nhs.uk/conditions/pulmonary-hypertension/treatment/</a></p><p> </p><p>NHS England commissions specialised PH services through the Specialised Respiratory Clinical Reference Group (CRG), which are available to all patients whose care is overseen by a specialist pulmonary arterial hypertension (PAH) centre in England.</p><p> </p><p>The policies regarding these specialised services are published on the NHS England Specialised Respiratory Clinical Reference Group website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a01/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a01/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:49:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

946981

	registered interest
	date	23/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the prescription charge is affordable for people on low incomes who pay those charges.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	167322
	answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Arrangements are in place to ensure that prescriptions are affordable for everyone. There are exemptions from the prescription charge for people with low income, including through receipt of specific benefits and through application to the NHS Low Income Scheme. The NHS Business Services Authority (NHSBSA) have developed an online tool to help patients find out what help with health costs they may be able to get and where to apply for it. For those who do not qualify for exemption, prescription prepayment certificates are also available, which allow people to claim as many prescriptions as they need for a set cost. To support those with high levels of need, the cost of the 12-month and 3-month certificates have been frozen since 2009 and 2011, respectively.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 17:00:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

924658

	registered interest
	date	15/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will fund approved diagnostics for diabetes.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	154175
	answer	answer is ministerial correction date of answer 25/06/2018 answer text <p>As part of the NHS Diabetes Prevention Programme, NHS England has provided implementation funding to local health economies (sustainability and transformation partnerships and their partner clinical commissioning groups, and local authorities) to support the identification, coding, and onward referral of those individuals at high risk of type 2 diabetes. Eligibility is defined by a blood glucose reading (HbA1C or FPG) within the last 12 months in the at risk category.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/06/2018 09:46:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

824708

	registered interest
	date	17/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Gray Zone Lymphoma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what public funds are available to treat patients suffering from gray zone lymphoma.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	123509
	answer	answer is ministerial correction date of answer 25/01/2018 answer text <p>Clinical commissioning groups take decisions on how their National Health Service budgets are spent on commissioning services to meet the needs of local populations, including those for gray zone lymphoma.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/01/2018 14:04:35 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

771528

	registered interest
	date	16/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Older People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many over-65s in (a) Southampton, (b) Portsmouth and (c) England have a long-term physical health condition.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	108039
	answer	answer is ministerial correction date of answer 24/10/2017 answer text <p>Data is not available in the format requested.</p><p> </p><p>Over 15 million children, adults and older people in England live with at least one long-term condition, such as diabetes, epilepsy or asthma.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 108037 question first answered 24/10/2017 10:51:38 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

771531

	registered interest
	date	16/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Older People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many over-65s in (a) Southampton, (b) Portsmouth and (c) England have a long-term health condition.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	108037
	answer	answer is ministerial correction date of answer 24/10/2017 answer text <p>Data is not available in the format requested.</p><p> </p><p>Over 15 million children, adults and older people in England live with at least one long-term condition, such as diabetes, epilepsy or asthma.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 108039 question first answered 24/10/2017 10:51:38 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

797507

	registered interest
	date	29/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure value for money on pharmaceutical procurement.
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	116470
	answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>For unbranded generics the Government relies on completion to keep prices down which generally works well and has led to low prices of these medicines. We alert the Competition and Markets Authority (CMA) when we believe that competition does not work. In the case of liothyronine, the CMA is currently investigating Concordia’s potential abuse of its dominant position to overcharge the National Health Service for liothyronine.</p><p> </p><p>In primary care community pharmacies are incentivised to source products at the lowest possible cost by allowing them to retain the medicines margin (the difference between what the NHS reimburses a pharmacy for a product and how much the pharmacy purchases it for) up to £800 million in England. In secondary care, competitive tenders ensure value-for-money to the NHS.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 116474 116477 116481 116482 question first answered 07/12/2017 15:27:25 answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith